Infectious Diseases and Antimicrobial Resistance
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 162
Special Issue Editor
Interests: mycobacterial diseases (TB and nontuberculous mycobacteria); respiratory viruses (influenza, RSV, COVID-19); pox infections; general clinical infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious diseases caused by viruses, bacteria, fungi and parasites have continued to scourge humans. Because of their ability to change and develop resistance to antimicrobials, infectious agents have become insurmountable challenges. Antimicrobial resistance is one of the biggest threats to public health worldwide. Although new antimicrobials have been developed and some new ones are in the pipeline, scientists mostly play catch-up as the infectious agents continue to change. In the last few decades, the existing problem of antimicrobial resistance is further complicated by the emergence of new and deadly infectious diseases that spread to the level of causing pandemic. As we have seen in the last three years alone from COVID-19 and Mpox pandemics, the focus on the control of emerging infectious diseases diverts funding and other resources from efforts to fight antimicrobial resistance. This leads to most dreadful scenario of fighting to curtail antimicrobial resistance to the plethora of infectious diseases in the middle of pandemics from newly emerged infectious diseases. Furthermore, emerging infectious diseases, like existing infectious diseases, change themselves and make available specific antimicrobials less effective. Therefore, this special issue will highlight past and current trends in antimicrobial resistant infectious diseases, prospects in developing new antimicrobials, application of new antimicrobials in the clinical practice, and possible future challenges.
You may choose our Joint Special Issue in Pathogens.
Dr. Getahun Abate
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial
- resistance
- infectious diseases
